305 related articles for article (PubMed ID: 10063312)
1. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.
Choi KC; Lee SC; Kim SW; Kim NH; Lee JU; Kang YJ
Korean J Intern Med; 1999 Jan; 14(1):32-41. PubMed ID: 10063312
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
[TBL] [Abstract][Full Text] [Related]
3. Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.
Komers R; Lindsley JN; Oyama TT; Allison KM; Anderson S
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F573-83. PubMed ID: 10966937
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
[TBL] [Abstract][Full Text] [Related]
5. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Komers R; Allen TJ; Cooper ME
Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
[TBL] [Abstract][Full Text] [Related]
7. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
[TBL] [Abstract][Full Text] [Related]
8. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
[TBL] [Abstract][Full Text] [Related]
9. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
Schwartz D; Schwartz IF; Blantz RC
J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
[TBL] [Abstract][Full Text] [Related]
10. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
De Vriese AS; Stoenoiu MS; Elger M; Devuyst O; Vanholder R; Kriz W; Lameire NH
Kidney Int; 2001 Jul; 60(1):202-10. PubMed ID: 11422752
[TBL] [Abstract][Full Text] [Related]
11. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration.
Bank N; Aynedjian HS
Kidney Int; 1993 Jun; 43(6):1306-12. PubMed ID: 8315943
[TBL] [Abstract][Full Text] [Related]
12. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
Anderson S; Chapman JG; Oyama TT; Komers R
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes.
Mattar AL; Fujihara CK; Ribeiro MO; de Nucci G; Zatz R
Nephron; 1996; 74(1):136-43. PubMed ID: 8883032
[TBL] [Abstract][Full Text] [Related]
14. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy.
Cadnapaphornchai MA; Ohara M; Morris KG; Knotek M; Rogachev B; Ladtkow T; Carter EP; Schrier RW
Am J Physiol Renal Physiol; 2001 Apr; 280(4):F592-8. PubMed ID: 11249850
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathy.
Wessels J; Peake P; Pussell BA; Macdonald GJ
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):451-3. PubMed ID: 9171957
[TBL] [Abstract][Full Text] [Related]
16. Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
Erley CM; Heyne N; Friedrich B; Schmidt T; Strobel U; Wehrmann M; Osswald H
J Cardiovasc Pharmacol; 2002 Nov; 40(5):780-8. PubMed ID: 12409987
[TBL] [Abstract][Full Text] [Related]
17. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats.
Goor Y; Peer G; Iaina A; Blum M; Wollman Y; Chernihovsky T; Silverberg D; Cabili S
Diabetologia; 1996 Sep; 39(9):1036-40. PubMed ID: 8877286
[TBL] [Abstract][Full Text] [Related]
19. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO.
Tolins JP; Shultz PJ; Raij L; Brown DM; Mauer SM
Am J Physiol; 1993 Dec; 265(6 Pt 2):F886-95. PubMed ID: 7506873
[TBL] [Abstract][Full Text] [Related]
20. Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.
Bell TD; DiBona GF; Biemiller R; Brands MW
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1449-56. PubMed ID: 18753304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
